Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
Letters to the Editor

Assessing stable coronary artery disease

Taher Modarressi, MD
Cleveland Clinic Journal of Medicine December 2020, 87 (12) 713; DOI: https://doi.org/10.3949/ccjm.87c.12003
Taher Modarressi
Diabetes & Endocrine Associates of Hunterdon, Hunterdon Medical Center, Flemington, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

To the Editor: The article by Nagaraja and Lincoff1 is an excellent review of the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches trial. It highlights the continuing evolution of patient-centered approaches in the management of stable coronary artery disease. Their algorithm contains the phrase “cardiac computed tomography to assess calcium score and exclude left main disease.” Are the authors referring to the coronary artery calcium score (CACS) or coronary computed tomography angiography (CCTA)? I believe they mean the latter, but as both are computed tomographic modalities of the heart and the difference may not be readily appreciated by a general medicine audience, it may be helpful to clarify.

The CACS is most useful in risk assessment in primary prevention, particularly to improve specificity in older adults and allow for a personalized and risk-driven decision in use of lipid-lowering medications. For patients with established coronary artery disease and an abnormal stress test, it seems unlikely that the CACS will add any clinically useful information and may provide false reassurance, particularly in exclusion of disease. Noncalcified plaque, including that in the left main, would not be visible on CACS.

Further, it is noncalcified plaque that is the strongest risk-discriminator. The incidence of acute coronary syndrome is associated with fibrofatty plaques and plaques with necrotic cores (both generally low-density, noncalcified plaque types that are not visualized by CACS), but not calcified plaque burden.2 Calcium development is a late-stage finding of a plaque, and high-risk atherosclerotic plaque features, such as rupture and erosion, are missed by CACS.3 In fact, heavily calcified (stabilized) plaques appear to be protective.4

On the other hand, CCTA evaluates the entire spectrum of coronary artery disease and can identify noncalcified plaque. It would be the appropriate modality to exclude left main disease, as I believe the authors are proposing.

  • Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Nagaraja V,
    2. Lincoff AM
    . Stable coronary artery disease: Intervene or not? Cleve Clin J Med 2020; 87(7):410–415. doi:10.3949/ccjm.87a.20048
    OpenUrlFREE Full Text
  2. ↵
    1. Chang HJ,
    2. Lin FY,
    3. Lee SE, et al
    . Coronary atherosclerotic precursors of acute coronary syndromes. J Am Coll Cardiol 2018; 71(22):2511–2522. doi:10.1016/j.jacc.2018.02.079
    OpenUrlFREE Full Text
  3. ↵
    1. Mori H,
    2. Torii S,
    3. Kutyna M, et al
    . Coronary artery calcification and its progression: what does it really mean? JACC Cardiovasc Imaging 2018; 11(1):127–142. doi:10.1016/j.jcmg.2017.10.012
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. van Rosendael AR,
    2. Narula J,
    3. Lin FY, et al
    . Association of high-density calcified 1K plaque with risk of acute coronary syndrome. JAMA Cardiol 2020; 5(3):282–290. doi:10.1001/jamacardio.2019.5315
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 87 (12)
Cleveland Clinic Journal of Medicine
Vol. 87, Issue 12
1 Dec 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessing stable coronary artery disease
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Assessing stable coronary artery disease
Taher Modarressi
Cleveland Clinic Journal of Medicine Dec 2020, 87 (12) 713; DOI: 10.3949/ccjm.87c.12003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Assessing stable coronary artery disease
Taher Modarressi
Cleveland Clinic Journal of Medicine Dec 2020, 87 (12) 713; DOI: 10.3949/ccjm.87c.12003
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Antiobesity drug therapy
  • Physician resistance to obesity pharmacotherapy
  • In Reply: Antiobesity drug therapy
Show more Letters to the Editor

Similar Articles

Subjects

  • Preventive Care
  • Imaging
  • Cardiology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire